Release Date: 01/06/16 11:23 Summary: Change of Director's Interest Notice (x3)-BRB.AX Price Sensitive: No Download Document 100.62KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%